hercules capital - HTGC
HTGC
Close Chg Chg %
18.81 -0.29 -1.54%
Pre-Market
18.52
-0.29 (1.54%)
Volume: 1.64M
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: hercules capital - HTGC
HTGC Key Data
| Open $18.90 | Day Range 18.51 - 18.90 |
| 52 Week Range 15.14 - 21.78 | Market Cap $3.06B |
| Shares Outstanding 162.45M | Public Float 159.50M |
| Beta 1.34 | Rev. Per Employee N/A |
| P/E Ratio 9.41 | EPS $2.01 |
| Yield 850.16% | Dividend $0.48 |
| EX-DIVIDEND DATE Nov 13, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.23M |
HTGC Performance
| 1 Week | -2.06% | ||
| 1 Month | -6.88% | ||
| 3 Months | 0.38% | ||
| 1 Year | 18.40% | ||
| 5 Years | 33.12% |
HTGC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
9
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 20.639 | |
| Number of Ratings | 9 | Current Quarters Estimate | 0.507 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 2.035 | |
| Last Quarter’s Earnings | 0.51 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.09 | Next Fiscal Year Estimate | 2.00 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 9 | 9 | 9 |
| Mean Estimate | 0.51 | 0.50 | 2.04 | 2.00 |
| High Estimates | 0.54 | 0.53 | 2.10 | 2.10 |
| Low Estimate | 0.49 | 0.48 | 2.01 | 1.89 |
| Coefficient of Variance | 3.42 | 3.81 | 1.43 | 3.50 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 4 | 4 | 4 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Hercules Capital - HTGC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Hercules Capital - HTGC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jul 16, 2024 | Kiersten Zaza Botelho General Counsel & CCO | 48,009 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.11 per share | 1,013,469.99 |
| Jul 16, 2024 | Seth H. Meyer Chief Financial Officer | 342,210 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.11 per share | 7,224,053.10 |
| Jul 16, 2024 | Christian Follmann Chief Operating Officer | 95,023 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.11 per share | 2,005,935.53 |
| Jul 16, 2024 | Scott Bluestein Chief Executive Officer | 2,261,207 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $21.11 per share | 47,734,079.77 |
| Jun 25, 2024 | Thomas J. Fallon Director | 8,096 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.8 per share | 160,300.80 |
| Jun 25, 2024 | Thomas J. Fallon Director | 85,519 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Thomas J. Fallon Director | 7,947 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Jun 25, 2024 | Gayle A. Crowell Director | 52,874 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.8 per share | 1,046,905.20 |
| Jun 25, 2024 | Nikos Theodosopoulos Director | 4,005 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $19.8 per share | 79,299.00 |
| Jun 25, 2024 | Robert P. Badavas Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 25, 2024 | Robert P. Badavas Director | 13,300 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Jun 25, 2024 | Robert P. Badavas Director | 4,234 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $19.69 per share | 83,367.46 |
| Jun 25, 2024 | Robert P. Badavas Director | 17,534 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $16.34 per share | 286,505.56 |
| Jun 25, 2024 | Robert P. Badavas Director | 4,234 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $19.6 per share | 82,986.40 |
| Jun 25, 2024 | Robert P. Badavas Director | 5,934 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $16.34 per share | 96,961.56 |
| Nov 28, 2023 | Wade W. Loo Director | 3,010 | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Nov 28, 2023 | Wade W. Loo Director | 3,101 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.87 per share | 49,212.87 |
| Nov 28, 2023 | Wade W. Loo Director | 16,180 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Nov 28, 2023 | Wade W. Loo Director | 16,679 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.56 per share | 259,525.24 |
| Nov 28, 2023 | Gayle A. Crowell Director | 47,740 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $15.72 per share | 750,472.80 |